Antipsychotic drugs may worsen metabolic control in type 2 diabetes mellitus

Journal of Clinical Psychiatry

Volumn 65, Issue 5, 2004, Pages 674-678

  Spoelstra, José A ^a,b   Stolk, Ronald P ^a   Cohen, Dan ^c   Klungel, Olav H ^b   Erkens, Joëlle A ^a,b   Leufkens, Hubertus G M ^b   Grobbee, Diederick E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c Rijngeestgroep   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN; NEUROLEPTIC AGENT;

ARTICLE; COMORBIDITY; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; MIDDLE AGED; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PROPORTIONAL HAZARDS MODEL; PSYCHOSIS; RISK FACTOR; TREATMENT FAILURE;

ANTIPSYCHOTIC AGENTS; BLOOD GLUCOSE; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; NETHERLANDS; PROPORTIONAL HAZARDS MODELS; PSYCHOTIC DISORDERS; RISK FACTORS; TREATMENT FAILURE;

EID: 2942726252     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v65n0512     Document Type: Article

References (26)

1. Cassidy F, Ahearn E, Carroll BJ. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry 1999;156:1417-1420 (Pubitemid 29416540)
2. Lilliker SL. Prevalence of diabetes in a manic-depressive population. Compr Psychiatry 1980;21:270-275 (Pubitemid 10027833)
3. Mukherjee S, Decina P, Bocola V, et al. Diabetes mellitus in schizophrenic patients. Compr Psychiatry 1996;37:68-73 (Pubitemid 26024880)
4. Polonsky KS, Sturis J, Bell GI. Non-insulin dependent diabetes mellitus: a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med 1996;334:777-783 (Pubitemid 26089361)
5. Hägg S, Joellsen L, Mjorndal T, et al. Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medication. J Clin Psychiatry 1998;59:294-299 (Pubitemid 28353977)
6. Brugman NJ, Cohen D, de Vries RH. Diabetes mellitus after treatment with clozapine [in Dutch]. Ned Tijdschr Geneeskd 2000;144:437-439 (Pubitemid 30111924)
7. Wirshing DA, Spellberg BJ, Erhart SM, et al. Novel antipsychotics and new onset diabetes. Biol Psychiatry 2001;44:778-783
8. Wilson DR, D'Souza L, Sarkar N. New-onset diabetes and ketoacidosis with atypical antipsychotics. Biol Psychiatry 2000;47:130S-131S
9. Mohan D, Gordon H, Hindley N, et al. Schizophrenia and diabetes mellitus [letter]. Br J Psychiatry 1999;174:180-181
10. Sobel M, Jaggers ED, Franz MA. New-onset diabetes mellitus associated with the initiation of quetiapine treatment [letter]. J Clin Psychiatry 1999;60:556-557 (Pubitemid 29413481)
11. Meltzer HY. The concept of an atypical antipsychotic drug. In: den Boer JA, Westenberg HGM, van Praag HM, eds. Advances in the Neurobiology of Schizophrenia. Chichester, England: John Wiley & Sons Ltd; 1995:265-274
12. Leucht S, Pitschel-Walz G, Abraham D, et al. Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo: a meta-analysis of randomized controlled trials. Schizophr Res 1999;35:51-68 (Pubitemid 29023554)
13. Arnesson GA. Phenothiazine derivatives and glucose metabolism. J Neuropsychiatry 1964;5:181-198
14. Hiles BW. Hyperglycemia and glucosuria following chlorpromazine therapy [letter]. JAMA 1956;162:1651
15. Thonnard-Neumann E. Phenothiazines and diabetes in hospitalized women. Am J Psychiatry 1968;124:978-982
16. Herings RMC, Bakker A, Stricker BH, et al. Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts. J Epidemiol Community Health 1992;46:136-140
17. Herings RMC. PHARMO: A Record Linkage System for Postmarketing Surveillance of Prescription Drugs in the Netherlands [thesis]. Utrecht, the Netherlands: Utrecht University; 1993
18. Nordic Statistics on Medicines 1981-1983, pt 2: Nordic Drug Index With Classification and Defined Daily Doses. Uppsala, Sweden: Nordic Council on Medicines; 1985
19. Kahn RS. Atypical antipsychotics [in Dutch]. Ned Tijdschr Geneeskd 2000;144:1627-1630
20. Anderson RJ, Freedland KE, Clouse RE, et al. The prevalence of comorbid depression in adults with diabetes. Diabetes Care 2001;24:1069-1078
21. Mukherjee S, Roth SD, Sandyk R, et al. Persistent tardive dyskinesia and neuroleptic effects on glucose tolerance. Psychiatry Res 1989;29:17-27 (Pubitemid 19189156)
22. Jeste DV, Gladsjo JA, Lindamer LA, et al. Medical comorbidity in schizophrenia. Schizophr Bull 1996;22:413-430 (Pubitemid 26295345)
23. Ardizzone TD, Bradley RJ, Freeman AM, et al. Inhibition of glucose transport in PC12 cells by the atypical antipsychotic drugs risperidone and clozapine, and structural analogs of clozapine. Brain Res 2001;923:82-90 (Pubitemid 34024939)
24. Ganguli R. Weight gain associated with antipsychotic drugs. J Clin Psychiatry 1999;60(suppl 21):20-24 (Pubitemid 29523629)
25. McIntyre RS, McCann SM, Kennedy SH. Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities. Can J Psychiatry 2001;46:273-281 (Pubitemid 32423994)
26. Henderson C, Cagliero E, Gray C, et al. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a 5-year naturalistic study. Am J Psychiatry 2000;57:975-981 (Pubitemid 30412350)